KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Interest Coverage Ratio (2016 - 2026)

Emergent BioSolutions has reported Interest Coverage Ratio over the past 16 years, most recently at 0.95 for Q1 2026.

  • For Q1 2026, Interest Coverage Ratio fell 71.88% year-over-year to 0.95; the TTM value through Mar 2026 reached 1.09, up 167.98%, while the annual FY2025 figure was 1.69, 210.26% up from the prior year.
  • Interest Coverage Ratio for Q1 2026 was 0.95 at Emergent BioSolutions, up from 1.9 in the prior quarter.
  • Over five years, Interest Coverage Ratio peaked at 7.77 in Q3 2024 and troughed at 12.29 in Q3 2023.
  • A 5-year average of 2.57 and a median of 1.9 in 2025 define the central range for Interest Coverage Ratio.
  • Biggest five-year swings in Interest Coverage Ratio: crashed 1284.87% in 2022 and later soared 163.23% in 2024.
  • Year by year, Interest Coverage Ratio stood at 4.32 in 2022, then soared by 53.28% to 2.02 in 2023, then surged by 68.2% to 0.64 in 2024, then crashed by 195.68% to 1.9 in 2025, then surged by 150.29% to 0.95 in 2026.
  • Business Quant data shows Interest Coverage Ratio for EBS at 0.95 in Q1 2026, 1.9 in Q4 2025, and 5.03 in Q3 2025.